Ruben Mesa: Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times!

Ruben Mesa, President at Atrium Health Levine Cancer, Executive Director at Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Vice Dean at Cancer Wake Forest School of Medicine, and SVP at Atrium Health, made the following post on LinkedIn:

“Glad to have the opportunity to discuss the FDA approval of momelotinib for patients with myelofibrosis in this interview with Pharmacy Times! Levine Cancer Institute Atrium Health Wake Forest Baptist Comprehensive Cancer Center Atrium Health Advocate Health GSK”

For details click here.
Source: Ruben Mesa/LinkedIn